BIAF · bioAffinity Technologies, Inc. · Held by Funds
$6.06
-0.09 (-1.46%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current expected level of operating expenditures, current expected levels of revenue, and the cash and cash equivalents on hand at June 30, 2026, of $2.4 million, management concludes that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements contained in this Quarterly Report.”View the 10-Q filed Aug 7, 2026
Market Cap
$3.72M
Shares
540,115
Volume · Oct 2
154.64K
Avg daily vol (29 sessions)
6.44M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BIAF
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | FSMAX | 28,059 | $46,859 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 55,543 | $45,101 | 0.00% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 7,639 | $12,757 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 6,517 | $10,883 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 3,114 | $5,200 | 0.00% | Long | 2026-05-31 |
Showing 1–5 of 5 positions